Wolverine Trading, LLC Axonics, Inc. Call Options Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$52.6 - $67.34 $120,980 - $154,882	-2,300 Reduced 31.08%	5,100 $277,000
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $440,744 - $566,840	7,400 New	7,400 $463,000
Q2 2022 Aug 15, 2022	SELL	$39.5 - $64.42 $31,600 - $51,536	-800 Reduced 17.39%	3,800 $219,000
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $230,046 - $337,410	4,600 New	4,600 $259,000
Q2 2021 Aug 06, 2021	SELL	$51.39 - $66.9 $190,143 - $247,530	-3,700 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$49.14 - $59.89 $181,818 - $221,593	3,700 New	3,700 $213,000
Q4 2020 Feb 12, 2021	SELL	$42.19 - $51.5 $278,454 - $339,900	-6,600 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$35.33 - $51.04 $45,929 - $66,352	-1,300 Reduced 16.46%	6,600 $325,000
Q2 2020 Aug 13, 2020	SELL	$22.91 - $39.83 $233,682 - $406,266	-10,200 Reduced 56.35%	7,900 $273,000
Q1 2020 May 11, 2020	BUY	$16.44 - $37.73 $297,564 - $682,913	18,100 New	18,100 $430,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.